3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
6
Gastrointestinal
4
Thoracic
2
Other hematologic neoplasm
2
NET
2
Lymphoid
2
Genitourinary
2
Endocrine
2
Breast
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
342
Rituximab
305
Vincristine
157
venetoclax
154
Doxorubicin
154
fludarabine
153
Specimen Handling
152
Prednisone
150
Biopsy
122
Magnetic Resonance Spectroscopy
117
obinutuzumab
116
Lenalidomide
109
Dexamethasone
104
Cytarabine
97
ibrutinib
95
Etoposide
93
fludarabine phosphate
87
Methotrexate
84
acalabrutinib
78
Bendamustine Hydrochloride
72
zanubrutinib
71
blinatumomab
63
pembrolizumab
62
CT-P10
60
Gemcitabine
51
Nivolumab
45
glofitamab
44
Calcium Dobesilate
44
Mercaptopurine
43
prednylidene
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Data Collection
×
Lymphoid
×
1 year
×
Clear all
NCT05583318
2025-07-23
LymphoVie 2
Centre Hospitalier Universitaire Dijon
Completed
1,570 enrolled
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled